• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

更正：Yes1信号传导介导乳腺癌对曲妥珠单抗/拉帕替尼的耐药性。

Correction: Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer.

出版信息

PLoS One. 2017 Mar 16;12(3):e0174493. doi: 10.1371/journal.pone.0174493. eCollection 2017.

DOI:10.1371/journal.pone.0174493
PMID:28301577
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5354437/
Abstract

[This corrects the article DOI: 10.1371/journal.pone.0171356.].

摘要

[本文更正了文章的数字对象标识符：10.1371/journal.pone.0171356。]

相似文献

1
Correction: Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer.更正：Yes1信号传导介导乳腺癌对曲妥珠单抗/拉帕替尼的耐药性。
PLoS One. 2017 Mar 16;12(3):e0174493. doi: 10.1371/journal.pone.0174493. eCollection 2017.
2
Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer.Yes1信号传导介导乳腺癌对曲妥珠单抗/拉帕替尼的耐药性。
PLoS One. 2017 Feb 3;12(2):e0171356. doi: 10.1371/journal.pone.0171356. eCollection 2017.
3
Correction: Trastuzumab effects depend on HER2 phosphorylation in HER2-negative breast cancer cell lines.更正：在HER2阴性乳腺癌细胞系中，曲妥珠单抗的作用取决于HER2磷酸化。
PLoS One. 2020 Oct 15;15(10):e0241089. doi: 10.1371/journal.pone.0241089. eCollection 2020.
4
Correction: Mutational Analysis of the Ve1 Immune Receptor That Mediates Verticillium Resistance in Tomato.更正：介导番茄对黄萎病抗性的Ve1免疫受体的突变分析
PLoS One. 2019 Jul 23;14(7):e0220402. doi: 10.1371/journal.pone.0220402. eCollection 2019.
5
Correction: Cryo-EM Structure of HER2-trastuzumab-pertuzumab complex.更正：HER2-曲妥珠单抗-帕妥珠单抗复合物的冷冻电镜结构
PLoS One. 2019 May 28;14(5):e0217716. doi: 10.1371/journal.pone.0217716. eCollection 2019.
6
Correction: The natural compound Jatrophone interferes with Wnt/β-catenin signaling and inhibits proliferation and EMT in human triple-negative breast cancer.更正：天然化合物麻风树素干扰Wnt/β-连环蛋白信号传导并抑制人三阴性乳腺癌的增殖和上皮-间质转化。
PLoS One. 2018 May 17;13(5):e0197796. doi: 10.1371/journal.pone.0197796. eCollection 2018.
7
Correction: Trail Resistance Induces Epithelial-Mesenchymal Transition and Enhances Invasiveness by Suppressing PTEN via miR-221 in Breast Cancer.更正：在乳腺癌中，肿瘤耐药通过miR-221抑制PTEN诱导上皮-间质转化并增强侵袭性。
PLoS One. 2019 Mar 21;14(3):e0214433. doi: 10.1371/journal.pone.0214433. eCollection 2019.
8
Correction: galectin-3 as a marker and potential therapeutic target in breast cancer.更正：半乳糖凝集素-3作为乳腺癌的标志物和潜在治疗靶点。
PLoS One. 2015 Jan 26;10(1):e0116994. doi: 10.1371/journal.pone.0116994. eCollection 2015.
9
Correction: breast cancer screening in Saudi Arabia: free but almost no takers.更正：沙特阿拉伯的乳腺癌筛查：免费但几乎无人参与。
PLoS One. 2015 Apr 8;10(4):e0124850. doi: 10.1371/journal.pone.0124850. eCollection 2015.
10
Correction: Correction: AKT Inhibitors Promote Cell Death in Cervical Cancer through Disruption of mTOR Signaling and Glucose Uptake.更正：更正：AKT抑制剂通过破坏mTOR信号传导和葡萄糖摄取促进子宫颈癌细胞死亡。
PLoS One. 2016 May 5;11(5):e0155168. doi: 10.1371/journal.pone.0155168. eCollection 2016.

本文引用的文献

1
Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer.Yes1信号传导介导乳腺癌对曲妥珠单抗/拉帕替尼的耐药性。
PLoS One. 2017 Feb 3;12(2):e0171356. doi: 10.1371/journal.pone.0171356. eCollection 2017.